Amanote Research

Amanote Research

    RegisterSign In

Review: Angiotensin II Receptor Blockers and Cardiovascular Outcomes: What Does the Future Hold?

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System - United Kingdom
doi 10.3317/jraas.2003.015
Full Text
Open PDF
Abstract

Available in full text

Categories
Internal MedicineEndocrinology
Date

June 1, 2003

Authors
Michael A Weber
Publisher

SAGE Publications


Related search

What Does the Future Hold for Yellow Fever Virus? (II)

2018English

Diabetic Nephropathy: What Does the Future Hold?

International Urology and Nephrology
UrologyNephrology
2015English

What Does the Future Hold for Otology?

Journal of Laryngology and Otology
MedicineOtorhinolaryngology
2019English

The Effect of Angiotensin II Receptor Blockers on Hyperuricemia

Therapeutic Advances in Chronic Disease
Medicine
2015English

Low-Calorie Sweeteners and Weight Management: What Does the Future Hold?

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

What Does the Future Hold for Top Down Mass Spectrometry?

Journal of the American Society for Mass Spectrometry
Structural BiologySpectroscopy
2010English

Angiotensin Receptor Blockers: Rational Prescription Tailored to the Cardiovascular Risk and Comorbidities

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

What Does the Future Hold for Life Sciences in the UK?

Prescriber
Pharmacology
2018English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy